Management of COVID-19-related immune thrombocytopenia by rhTPO. | Blood Res;56(3): 205-207, 2021 Sep 30. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Management of COVID-19-related immune thrombocytopenia by rhTPO.

Zhang, Xuzhao; Li, Min; Chen, Tao; Lv, Dong; Xia, Pengfei; Qian, Wenbin.

Zhang X; Department of Hematology, Hangzhou, China.
Li M; Aid Hubei Medical Team, Hangzhou, China.
Chen T; Aid Hubei Medical Team, Hangzhou, China.
Lv D; Neurology Intensive Care Unit, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xia P; Aid Hubei Medical Team, Hangzhou, China.
Qian W; Neurology Intensive Care Unit, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Blood Res ; 56(3): 205-207, 2021 Sep 30.

Article in English | MEDLINE | ID: covidwho-1380049

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Blood Res Year: 2021 Document Type: Article Affiliation country: Br.2021.2020049

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Blood Res Year: 2021 Document Type: Article Affiliation country: Br.2021.2020049